CAS: 1942-52-5; 2-Diethylaminoethanethiol Hydrochloride

该化合物是一种含有硫醇的化合物,其第三类汞功能组,通常用于有机合成和制药用途,其主要优点包括它作为准备硫醚衍生物的多用途构件和作为协调化学的离子体.盐的形态增强了水系的稳定性和溶性,便利了处理和储存.该化合物的活性硫醇组群可以与电极高效结合,而二乙基氨基混合物则有助于其在对pH敏感的反应中的实用性.它在开发需要受控反应的药物候选物和功能材料方面特别宝贵.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号100-35-6 N,N-二乙基氯乙胺 | CAS号55297-95-5 泰妙菌素 | CAS号589-32-2 四乙基胱胺-13C4

合成工艺路线路线简述

    N,N-二乙基氯乙胺置于盐酸体系中,用 乙醇,水 用作溶剂,化学反应 6.5H,反应生成2-二乙氨基乙硫醇盐酸盐
    参考文献:Russo; Santagati; Venturini,Pharmazie,1990,Vol. 45,# 7,P. 493-495
    标题:Russo; Santagati; Venturini,Pharmazie,1990,Vol. 45,# 7,P. 493-495

    海关参考信息

    专利信息


    专利号:WO-2014128524-A1
    优先权日:2013-02-19
    标题:An improved process for preparation of an intermediate of the pyrrolidine substituted flavones
    发明人:CHENNAMSETTY SUNEELMANOHARBABU; PATIL RAJENDRA; HAREL PRASHANT; HARIHARAN SIVARAMAKRISHNAN
    权利人:PIRAMAL ENTPR LTD
    摘要:The present invention relates to a process for the preparation of a key intermediate (as described herein) used in the synthesis of (+)- trans enantiomer of pyrrolidine substituted flavones, represented by the compounds of formula (1) or pharmaceutically acceptable salts thereof; which are inhibitors of cyclin dependant kinases (CDKs) and can be used in the treatment of proliferative disorders such as cancer. Formula (1) wherein R 1 has the meaning as indicated in the claims. The process of the present invention has advantages of higher yield and purity, lower reaction temperature, is consistent and involves the use of non toxic solvents. The process of the present invention allows efficient large-scale synthesis and purity of the product obtained is greater than 97 %.

    专利号:WO-2014128523-A1
    优先权日:2013-02-19
    标 题 :A process for preparation of an intermediate of the pyrrolidine substituted flavones
    发明人:CHENNAMSETTY SUNEELMANOHARBABU; BOKKA RAVISHANKAR; VEERAPPAN RATHINASAMI; SIVAKUMAR MEENAKSHI; HARIHARAN SIVARAMAKRISHNAN
    权利人:PIRAMAL ENTPR LTD
    摘要:The present invention relates to a process for the preparation of a key intermediate (as described herein) used in the synthesis of (+)- trans enantiomer of pyrrolidine substituted flavones, represented by the compounds of formula (1) or pharmaceutically acceptable salts thereof; which are inhibitors of cyclin dependant kinases (CDKs) and can be used in the treatment of proliferative disorders such as cancer. Formula (1) wherein R has the meaning as indicated in the claims. The process of the present invention has advantages of higher yield and purity, lower reaction temperature, is consistent and involves the use of non toxic solvents. The process of the present invention allows efficient large-scale synthesis and purity of the product obtained is greater than 97 %.

    专利号:US-2008242877-A1
    优先权日:2007-02-26
    标题 :Intermediates and processes for the synthesis of Ramelteon
    发明人:KANSAL VINOD KUMAR; MISTRY DHIRENKUMAR N; VASOYA SANJAY L
    权利人:KANSAL VINOD KUMAR; MISTRY DHIRENKUMAR N; VASOYA SANJAY L
    摘要:Provided are intermediates and processes for preparation of Ramelteon.

    专利号:US-2018208555-A1
    优先权日:2013-11-18
    标题 :Method of synthesis of an ionizable cationic lipid

    专利号:US-10781169-B2
    优先权日:2013-11-18
    标 题:Method of synthesis of an ionizable cationic lipid

    专利号:US-2021002217-A1
    优先权日:2013-11-18
    标题:Method of synthesis of an ionizable cationic lipid
    江苏贵仁医药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.guirenchem.com
    电话:0519-83489086;13601507568👤
    📞 江苏贵仁医药有限公司⚠️参考联系方式

    电话: 0519-83489086;13601507568
    邮件:sales@guirenchem.com
    网址: http://www.guirenchem.com
    地址:江苏省常州市芮城县风陵渡开发区振兴北街北侧
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    江苏省常州市芮城县风陵渡开发区振兴北街北侧
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别. 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/978-1-60761-447-0_20
    摘要:Arias HR. Interaction of lipids and ligands with nicotinic acetylcholine receptor vesicles assessed by electron paramagnetic resonance spectroscopy. Methods Mol Biol. 2010;606():291–318. doi: 10.1007/978-1-60761-447-0_20.
    摘要:National Technical Information Service., AD277-689
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知